A Dallas-based biopharmaceutical company is set to be acquired in a deal that clocks in at about $2.2 billion and signals optimism around its early-stage immunology research.<\/p>\n
Belgian-Dutch pharmaceutical company argenx<\/a> announced its intention on Monday to acquire Forte Biosciences Inc.<\/a> for $77 per share in an all-cash deal.<\/p>\n Forte Biosciences specializes in research on FB102, a \u201cproprietary molecule\u201d the company says has significant potential to address autoimmune conditions such as celiac disease, vitiligo, alopecia areata and Type 1 diabetes. It had 22 employees as of March 31, according to a quarterly financial filing.<\/p>\n Forte Biosciences announced positive data from a celiac disease study in June 2025, with more data expected this year from Phase 2 of the study, according to its website. The company also reported positive data from a vitiligo study earlier this month, and data from alopecia areata trials is expected later this year.<\/p>\n The studies were \u201ckey drivers\u201d of Argenx\u2019s decision to pursue the buyout as it seeks to become \u201cthe leading immunology innovator of the future,\u201d Argenx CEO Karen Massey said in a news release announcing the deal. Its portfolio already includes other antibody-based programs, including\u00a0efgartigimod, empasiprubart, adimanebart and ARGX-121.<\/p>\n \u201cOur discovery, development and commercialization engines are delivering real value for patients,\u201d she said in the statement. \u201cThe addition of FB102 to our portfolio aligns perfectly with the argenx playbook: compelling biology, strong clinical validation and broad potential to address patient need.\u201d<\/p>\n The company is in the clinical trial stage and has not generated any revenue. It reported losses of $69 million in 2025.<\/p>\n Shares of Forte Biosciences\u00a0jumped by nearly 40% to around $76 following the announcement. Argenx, on the other hand, saw its shares fall about 3%, closing at $888.82 on Monday.<\/p>\n Forte Biosciences CEO Paul Wagner hopes that combining his company\u2019s \u201cpromising clinical profile\u201d with Argenx\u2019s more established development process will be a recipe for success.<\/p>\n \u201cWe are excited about the future of FB102 and the potential to bring this innovative therapy to many more patients worldwide,\u201d he said in a statement.<\/p>\n The boards of directors of both companies have approved the transaction. It is expected to close in the third quarter of 2026.<\/p>\n","protected":false},"excerpt":{"rendered":"A Dallas-based biopharmaceutical company is set to be acquired in a deal that clocks in at about $2.2…\n","protected":false},"author":2,"featured_media":388883,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[102,104,103],"class_list":["post-388882","post","type-post","status-publish","format-standard","has-post-thumbnail","category-dallas","tag-dallas","tag-dallas-headlines","tag-dallas-news"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/posts\/388882","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/comments?post=388882"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/posts\/388882\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/media\/388883"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/media?parent=388882"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/categories?post=388882"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/tags?post=388882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}